New filing expands NorthStrive Biosciences’ pu
Author: Michael
Real-time clinical trials could accelerate drug
A genome pioneer who read life as code – and r
BioCardia announced the allowance of a Japanese p
Insilico Medicine announced that the inhalation f
Alector confirmed it will discontinue the Phase 2
Stealth provided a commercial and research update
Renibus announced that data from the Phase 3 PROT
Deal strengthens cyclodextrin IP targeting ApoE4
A new obesity approach targets fat storage pathw